SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Qi Meng, Yun Shen, Dajin Liu, Fei Jiang, Efficacy of canagliflozin combined with antidiabetic drugs in treating type 2 diabetes mellitus: Meta-analysis of randomized control trials, Journal of Diabetes Investigation, 2016, 7, 1
  2. 2
    William T. Cefalu, George A. Bray, Philip D. Home, W. Timothy Garvey, Samuel Klein, F. Xavier Pi-Sunyer, Frank B. Hu, Itamar Raz, Luc Van Gaal, Bruce M. Wolfe, Donna H. Ryan, Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From aDiabetes CareEditors’ Expert Forum, Diabetes Care, 2015, 38, 8, 1567

    CrossRef

  3. 3
    Gary Meininger, William Canovatchel, David Polidori, Norm Rosenthal, Canagliflozin for the treatment of adults with Type 2 diabetes, Diabetes Management, 2015, 5, 3, 183

    CrossRef

  4. 4
    Norm Rosenthal, Gary Meininger, Kirk Ways, David Polidori, Mehul Desai, Rong Qiu, Maria Alba, Frank Vercruysse, Dainius Balis, Wayne Shaw, Robert Edwards, Scott Bull, Nicholas Di Prospero, Sue Sha, Paul Rothenberg, William Canovatchel, Keith Demarest, Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus, Annals of the New York Academy of Sciences, 2015, 1358, 1
  5. 5
    K. Fujioka, Current and emerging medications for overweight or obesity in people with comorbidities, Diabetes, Obesity and Metabolism, 2015, 17, 11
  6. 6
    Jonathan R. S. Arch, Horizons in the Pharmacotherapy of Obesity, Current Obesity Reports, 2015, 4, 4, 451

    CrossRef

  7. 7
    Konstantinos P. Imprialos, Pantelis A. Sarafidis, Asterios I. Karagiannis, Sodium–glucose cotransporter-2 inhibitors and blood pressure decrease, Journal of Hypertension, 2015, 33, 11, 2185

    CrossRef

  8. 8
    Luc Van Gaal, André Scheen, Weight Management in Type 2 Diabetes: Current and Emerging Approaches to Treatment, Diabetes Care, 2015, 38, 6, 1161

    CrossRef

  9. 9
    Alisa K. Escaño, A worldwide yearly survey of new data in adverse drug reactions, 2015,

    CrossRef

  10. 10
    Greg L. Plosker, Canagliflozin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus, Drugs, 2014, 74, 7, 807

    CrossRef

  11. 11
    V Margaret Jackson, David A Price, Philip A Carpino, Investigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies, Expert Opinion on Investigational Drugs, 2014, 23, 8, 1055

    CrossRef

  12. 12
    Y.-M. D., Traiter le diabète de type 2… et le surpoids, Option/Bio, 2014, 25, 501, 11

    CrossRef